Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

25 trials with published results (11%)

Research Maturity

115 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.6%

8 terminated out of 222 trials

Success Rate

93.5%

+6.9% vs benchmark

Late-Stage Pipeline

13%

28 trials in Phase 3/4

Results Transparency

22%

25 of 115 completed with results

Key Signals

25 with results93% success

Data Visualizations

Phase Distribution

195Total
Not Applicable (51)
Early P 1 (3)
P 1 (93)
P 2 (20)
P 3 (13)
P 4 (15)

Trial Status

Completed115
Unknown44
Recruiting27
Not Yet Recruiting15
Terminated8
Active Not Recruiting7

Trial Success Rate

93.5%

Benchmark: 86.6%

Based on 115 completed trials

Clinical Trials (222)

Showing 20 of 20 trials
NCT07855354Not ApplicableRecruitingPrimary

Safety and Efficacy of Papillary Versus NonPapillary Access During Percutaneous Nephrolithotomy

NCT07797192Not ApplicableCompletedPrimary

Evaluation of Allergenicity by HRIPT and Phototest

NCT06717867Phase 2Active Not Recruiting

Long-Term PEA Safety Study

NCT07461220Phase 1Recruiting

Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

NCT02467946Phase 1Completed

Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient

NCT07789327Phase 1Not Yet RecruitingPrimary

Phase 1/2 Clinical Study of HY07121 for Injection (Subcutaneous) in Patients With Advanced Solid Tumors

NCT07285967Phase 1Not Yet RecruitingPrimary

A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet

NCT07722884Not ApplicableRecruitingPrimary

Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH

NCT06733675Phase 1Recruiting

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

NCT07663838Phase 1Not Yet Recruiting

A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)

NCT07660107Not ApplicableCompletedPrimary

Safety and Tolerability of Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) - a Pilot Study

NCT06990893Not ApplicableRecruiting

Comparison of the Analgesic Effect of Oliceridine Versus Morphine or Sufentanil for Postoperative Analgesia in Lumbar Surgeries: a Randomized Control Trial

NCT07604038Not ApplicableCompleted

Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) for Stress, Sleep, and Inflammation

NCT05173922Not ApplicableCompleted

"Safety in Dementia": An Online Caregiver Intervention

NCT07576322Not ApplicableNot Yet Recruiting

Short-Term Safety and Performance of Two Wound Dressings Evaluation

NCT07572448Not Yet Recruiting

The Relationship Between Nurses' Perception Of Safety Culture And Patients' Sense Of Safety

NCT07454538Not ApplicableCompletedPrimary

Empowering Preschool Children With Personal Safety Skills

NCT07557966Not ApplicableCompletedPrimary

Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis

NCT06844487Phase 3Active Not Recruiting

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC

NCT07000669CompletedPrimary

Bilateral Peribulbar Block for Cataract Surgery

Scroll to load more

Research Network

Activity Timeline